John J. Lee

Plasma-Based Measurements of Tumor Heterogeneity Correlate with Clinical Outcomes in Metastatic Colorectal Cancer

H. Hurwitz, S. Yaung, J. Bendell, 2022, Cancers.

Early prediction of clinical outcomes in resected stage II and III colorectal cancer (CRC) through deep sequencing of circulating tumor DNA (ctDNA).

Ash A. Alizadeh, Aaron M. Newman, A. Newman, 2017 .

Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer

H. Hurwitz, S. Yaung, J. Bendell, 2020, Clinical Cancer Research.

Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM).

J. Reeves, B. Somer, H. Lenz, 2019, The oncologist.